tiprankstipranks
Advertisement

EES - ETF AI Analysis

Compare

Top Page

EES

WisdomTree U.S. SmallCap Fund (EES)

Rating:67Neutral
Price Target:
EES, the WisdomTree U.S. SmallCap Fund, has a generally positive overall rating, suggesting it holds a mix of promising small-cap stocks with some notable risks. Strong contributors like Matson, Northern Oil and Gas, and Bread Financial support the fund’s quality through solid valuations, constructive earnings calls, and mostly favorable technical trends. However, weaker names such as Sarepta Therapeutics, with significant profitability and cash flow issues, and several holdings facing high leverage or bearish momentum, introduce risk, so investors should be mindful that some companies in the portfolio have financial and technical headwinds.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Generally Positive Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating supportive recent momentum.
No Single Dominant Holding
Each top holding makes up only a small slice of the portfolio, limiting the damage if any one stock runs into trouble.
Negative Factors
High U.S.-Only Exposure
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Mixed Performance Among Top Holdings
Several of the largest positions have shown weak or negative year-to-date performance, which can drag on overall returns.
Above-Average Expense Ratio for an ETF
The fund’s expense ratio is on the higher side for an ETF, which slightly reduces the net return investors keep over time.

EES vs. SPDR S&P 500 ETF (SPY)

EES Summary

The WisdomTree U.S. SmallCap Fund (EES) is an ETF that tracks the WisdomTree U.S. SmallCap Index, focusing on smaller U.S. companies across many industries like financials, technology, and consumer businesses. It holds a wide mix of stocks, including well-known names such as Western Union and Levi Strauss. Investors might consider EES if they want growth potential from smaller, more agile companies and broader diversification beyond large, familiar brands. However, small-cap stocks can be more volatile than larger companies, so the fund’s value can rise and fall more sharply with changes in the market.
How much will it cost me?The WisdomTree U.S. SmallCap Fund (EES) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it tracks a specialized index of small-cap stocks, which requires more active management compared to broad-market passive funds.
What would affect this ETF?The WisdomTree U.S. SmallCap Fund (EES) could benefit from economic growth and increased consumer spending, which often drive small-cap companies in sectors like Consumer Cyclical and Technology. However, rising interest rates or economic slowdowns may negatively impact small-cap stocks, particularly in sectors like Financials and Industrials, which make up a significant portion of the fund. Regulatory changes or geopolitical uncertainties could also affect the U.S.-focused portfolio and its top holdings in industries like Energy and Health Care.

EES Top 10 Holdings

EES is leaning into U.S. small caps with a noticeable tilt toward financials and energy, and that mix is shaping returns. Venture Global and Crescent Energy have been rising, giving the fund a lift from the energy patch, while Northern Oil and Gas adds to that momentum. On the flip side, Western Union has been losing steam and DXC Technology is clearly dragging, reflecting more troubled stories in financials and tech. Overall, this is a domestically focused, broadly diversified small-cap play, but a handful of volatile names are steering the ride.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Venture Global, Inc. Class A2.25%$14.03M$41.50B63.98%
58
Neutral
Crescent Energy Company Class A0.90%$5.59M$4.44B20.46%
66
Neutral
Northern Oil And Gas0.70%$4.38M$2.91B-1.06%
72
Outperform
Matson0.68%$4.26M$4.79B22.77%
77
Outperform
BGC Group0.63%$3.91M$4.52B4.03%
65
Neutral
Western Union0.58%$3.62M$2.74B-17.39%
69
Neutral
Virtu Financial0.55%$3.44M$6.63B12.38%
64
Neutral
Bread Financial Holdings0.54%$3.36M$3.15B45.83%
72
Outperform
RingCentral0.54%$3.34M$3.05B46.28%
63
Neutral
Sarepta Therapeutics0.52%$3.25M$2.15B-67.91%
51
Neutral

EES Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
59.08
Negative
100DMA
57.82
Negative
200DMA
55.66
Positive
Market Momentum
MACD
-0.50
Negative
RSI
41.81
Neutral
STOCH
53.33
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EES, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 57.74, equal to the 50-day MA of 59.08, and equal to the 200-day MA of 55.66, indicating a neutral trend. The MACD of -0.50 indicates Negative momentum. The RSI at 41.81 is Neutral, neither overbought nor oversold. The STOCH value of 53.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EES.

EES Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$632.32M0.38%
67
Neutral
$870.60M0.48%
72
Outperform
$845.58M0.20%
65
Neutral
$666.88M0.09%
64
Neutral
$663.62M0.42%
68
Neutral
$623.22M0.40%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EES
WisdomTree U.S. SmallCap Fund
57.00
8.15
16.68%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
JHSC
John Hancock Multifactor Small Cap ETF
SMDV
ProShares Russell 2000 Dividend Growers ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement